Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease
(NASDAQ: JUNS) Delayed: 0.23 -0.01 (4.17%)
Previous Close $0.24    52 Week High $ 
Open $0.24    52 Week Low $ 
Day High $0.24    P/E N/A 
Day Low $0.23    EPS $ 
Volume 935,809       

(NASDAQ: JUNS) Delayed: 0.23 -0.01 (4.17%)
Previous Close $0.24    52 Week High $ 
Open $0.24    52 Week Low $ 
Day High $0.24    P/E N/A 
Day Low $0.23    EPS $ 
Volume 935,809       

(NASDAQ: JUNS) Delayed: 0.23 -0.01 (4.17%)
Previous Close $0.24    52 Week High $ 
Open $0.24    52 Week Low $ 
Day High $0.24    P/E N/A 
Day Low $0.23    EPS $ 
Volume 935,809